Investigation Overview
Mar. 1, 2013 (Shareholders Foundation) -- An investigation on behalf of investors of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares over potential securities laws violations by Rigel Pharmaceuticals, Inc. and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchas...
You must register (for free) or login to view the entire investigation.